Drug Resistance in the Microaerophilic Parasite Giardia lamblia

The microaerophilic parasite Giardia lamblia is a causative agent of dysentery affecting hundreds of millions of people around the globe every year. The symptoms of the disease, commonly referred to as giardiasis, are diarrhea, nausea, and malabsorption. Treatment of giardiasis is exclusively based...

Descripción completa

Detalles Bibliográficos
Autor principal: Leitsch, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Protozoa (Giardia) (SM Singer, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523694/
https://www.ncbi.nlm.nih.gov/pubmed/26258002
http://dx.doi.org/10.1007/s40475-015-0051-1
_version_ 1782384091401814016
author Leitsch, David
author_facet Leitsch, David
author_sort Leitsch, David
collection PubMed
description The microaerophilic parasite Giardia lamblia is a causative agent of dysentery affecting hundreds of millions of people around the globe every year. The symptoms of the disease, commonly referred to as giardiasis, are diarrhea, nausea, and malabsorption. Treatment of giardiasis is exclusively based on chemotherapy with antigiardial drugs, including metronidazole, albendazole, and nitazoxanide. In this review, all drugs currently used in the treatment of Giardia infections are discussed with a special emphasis on treatment failure and drug resistance.
format Online
Article
Text
id pubmed-4523694
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-45236942015-08-06 Drug Resistance in the Microaerophilic Parasite Giardia lamblia Leitsch, David Curr Trop Med Rep Protozoa (Giardia) (SM Singer, Section Editor) The microaerophilic parasite Giardia lamblia is a causative agent of dysentery affecting hundreds of millions of people around the globe every year. The symptoms of the disease, commonly referred to as giardiasis, are diarrhea, nausea, and malabsorption. Treatment of giardiasis is exclusively based on chemotherapy with antigiardial drugs, including metronidazole, albendazole, and nitazoxanide. In this review, all drugs currently used in the treatment of Giardia infections are discussed with a special emphasis on treatment failure and drug resistance. Springer International Publishing 2015-07-07 2015 /pmc/articles/PMC4523694/ /pubmed/26258002 http://dx.doi.org/10.1007/s40475-015-0051-1 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Protozoa (Giardia) (SM Singer, Section Editor)
Leitsch, David
Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title_full Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title_fullStr Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title_full_unstemmed Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title_short Drug Resistance in the Microaerophilic Parasite Giardia lamblia
title_sort drug resistance in the microaerophilic parasite giardia lamblia
topic Protozoa (Giardia) (SM Singer, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523694/
https://www.ncbi.nlm.nih.gov/pubmed/26258002
http://dx.doi.org/10.1007/s40475-015-0051-1
work_keys_str_mv AT leitschdavid drugresistanceinthemicroaerophilicparasitegiardialamblia

Ejemplares similares